Skip to content Skip to sidebar Skip to footer

Adopting Precision Immunotherapy for Improved Sepsis Outcomes: Insights from the ImmunoSep Trial

The challenge of treating sepsis, an intricate and formidable critical health condition arising from an extreme reaction to infection, continues in healthcare facilities across the globe. Each year, millions fall victim to this life-threatening form of organ dysfunction, calling for more effective healthcare solutions. New insights gleaned from the ImmunoSep trial suggest that an advanced…

Read more

Strategic Shift in Categorization of Human Experimental Studies: Implications for Infection Prevention

In a recent development, the National Institutes of Health (NIH) has announced a newly revised categorization for basic experimental studies involving humans (BESH). As per the agency's announcement on January 29, BESH applications will not be subjected to clinical trial requirements effective from May 25, 2026. However, there remains an expectation for such studies to…

Read more

Unveiling Efficacy and Security of Fecal Microbiota Therapy: Rebyota in Real-World Data

Delving into the real-world efficacy and safety of fecal microbiota or Rebyota outlined by Paul Feuerstadt, MD, paints a considerably reassuring picture of this therapeutic agent in dealing with recurrent C difficile. Rebyota has enjoyed FDA approval for over two years, and Dr. Feuerstadt, associate clinical professor of Medicine at Yale School of Medicine, who…

Read more

Clinical Trial Investigation: Efficacy of Topical Gentamicin in Surgical Site Infection Prophylaxis

Surgical site infections (SSIs) remain widespread in spite of development in surgical techniques and preventive measures. As such, treatment methods continue to be evaluated to find promising solutions. One such method involves the use of topical antibiotics such as gentamicin. This article delves into a recent randomized controlled trial aiming to assess the effectiveness of…

Read more

Ondine Biomedical Accelerates Path-breaking Antimicrobial Trials, Boosts Fight against Hospital-Associated Infections

Ondine Biomedical, a Canadian company specializing in life sciences, has declared that it is stepping up the final preparations to kick off its key US Phase 3 clinical trial in Q4 2024. This acceleration comes in the wake of a successful fundraiser that totalled Cdn $16 million (US $11m), attracting substantial support from existing institutional…

Read more

Innovating Infection Prevention: Deriving Insights from the IMPACT Grand Rounds Led by Dr. Susan Huang

The IMPACT Collaboratory recently hosted Dr. Susan Huang, a renowned medical professional and impactful authority in the realm of healthcare-associated infections and multidrug-resistant organisms (MDROs), for one of the grand rounds. Dr. Huang's position as a professor at the University of California Irvine School of Medicine, in the Division of Infectious Diseases and the Health…

Read more

Pioneering Nasal COVID-19 Vaccine Trials and What It Means for The Future

A hospital on Long Island is one of three sites nationally spearheading clinical trials for an experimental nasal COVID-19 vaccine. This vaccine could potentially diminish disease transmission and infection rates, offering fresh hope in the ongoing pandemic. The trials are taking place at NYU Langone Hospital-Long Island in Mineola, which is actively recruiting eligible adults…

Read more

Revolutionizing the Treatment of Infections: Intriguing Clinical Advancements in Antibiotic Therapy, Antivirals and Vaccines

A recent study published in The Lancet Infectious Diseases announced transformative results from a randomized clinical trial focusing on patients with low-risk Staphylococcus aureus bloodstream infections. The trial conducted across 31 hospitals in Germany, France, the Netherlands, and Spain, showed that an early switch from intravenous (IV) to oral antibiotic therapy was as effective as…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]